p53 reactivator

p53 is a transcription factor often called the guardian of the genome. In healthy cells it senses DNA damage, oncogenic stress, and other insults, then activates genes that halt cell division, promote repair, or trigger programmed cell death (apoptosis). This tumor-suppressor function is lost in a very large proportion of human cancers, most commonly through point mutations in the TP53 gene that distort the protein's three-dimensional structure rather than deleting it outright. Many such mutant proteins are still present in tumor cells but are misfolded and functionally inert, unable to bind DNA or activate protective genes. A p53 reactivator is a small molecule designed to bind the mutant protein and stabilize a folded, transcriptionally active conformation, essentially restoring tumor-suppressor activity that the cancer cell had disabled. Because a single amino-acid substitution can be responsible, reactivators are often designed for a specific structural mutation rather than for p53 broadly. This approach is relevant across many solid and hematologic cancers, since TP53 mutation is one of the most frequent genetic events in oncology, and restoring native surveillance and death pathways in tumor cells offers a route to selectively suppress malignant growth while, in principle, sparing cells with normal p53.